• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 42050120-120
Device Problems Material Separation (1562); Difficult to Advance (2920); Mechanical Jam (2983); Activation Failure (3270)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/12/2023
Event Type  Injury  
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event Description
It was reported that the procedure was to treat a moderately calcified, moderately tortuous right distal superior femoral artery (sfa).The patient was treated crossover, puncturing the left common femoral artery and the bifurcation was noted to be stiff.The lesion was prepped with an unspecified 6mm balloon for five minutes at rate burst pressure.The 5.0x120mm supera self-expanding stent system (sess) was advanced to lesion with some resistance felt with anatomy; however, during deployment the stent partially deployed.It was not possible to open the second red lock to release the last proximal section of the stent.It was attempted to retrieve the supera back into the sheath, but the delivery system separated at the distal shaft.Fortunately, the olive got stuck in the stent.The delivery system was removed under fluoroscopy.The 6f sheath was replaced with an 11f and was able to snare the separated portion and remove from the anatomy.To end the procedure the lesion was treated with a new 5.0x100mm supera.There was no adverse patient sequela and no clinically significant delay.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported material separation was able to be confirmed.The reported mechanical jam was unable to be confirmed.The reported activation failure was unable to be replicated in a testing environment due to the condition of the returned device.The reported difficult to advance was unable to be replicated in a testing environment as it was based on operational circumstances.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.As there was no damage noted to the device during the inspection prior to use, the investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that during advancement resistance was met with the moderately calcified, moderately tortuous anatomy resulting in the reported difficult to advance.During stent deployment it is likely that the distal sheath of the delivery system was entrapped or bent in the moderately calcified, moderately tortuous anatomy and the noted stiff bifurcation resulting in the noted device damages (entire length of the sheath bent sporadically, chatter marks/bends sporadically on the entire length of catheter shaft) such that the ratchet was unable to properly/fully deploy the stent resulting in the reported activation/deployment failure and the reported mechanical jam.Interaction/manipulation of the device in an attempt to retrieve the supera back into the sheath ultimately resulted in the reported material separation/noted tip jacket and inner member separations.The treatment(s) appears to be related to the operational context of the procedure as reportedly the 6f sheath was replaced with an 11f and was able to snare the separated portion and remove from the anatomy.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17074052
MDR Text Key316661001
Report Number2024168-2023-05959
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number42050120-120
Device Lot Number2102761
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/15/2023
Initial Date FDA Received06/06/2023
Supplement Dates Manufacturer Received07/21/2023
Supplement Dates FDA Received07/28/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/27/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
TERUMO DESTINATION 6F CROSSOVER SHEATH
Patient Outcome(s) Required Intervention;
-
-